Triticum

Company Overview

Snapshot

Founded in January 2012 by Doron Ben Ami, Triticum operates with 1-10 employees. The company is developing a clot-retrieval device for acute ischemic stroke and peripheral vessel occlusions, having secured one funding round.

Business overview

Triticum Medical is a Health Tech & Life Sciences company focused on developing a clot-retrieval device for the treatment of acute ischemic stroke and occlusions in peripheral vessels. Its core technology utilizes a soft polymer with micro-surfaces, inspired by biological concepts, to engage and retrieve clots from blood vessels. The company operates within the Medical Devices sector, specifically targeting Medical Treatment & Therapeutics, and serves the Healthcare industry globally.

Company Intelligence Q&A

What is Triticum's primary focus?

Triticum is developing a clot-retrieval device designed for the treatment of acute ischemic stroke and occlusions in peripheral vessels.

When was Triticum founded?

Triticum was founded in January 2012.

Who is the founder of Triticum?

Doron Ben Ami is the founder and CEO of Triticum.

What is the key technology behind Triticum's device?

Triticum's device is made of soft polymer and utilizes micro-surfaces technology to engage with the clot's micro-structure, inspired by biological concepts.

What is Triticum's current funding stage?

Triticum is currently in the Pre-Seed funding stage, having secured its first funding round in June 2018.